Why Device Trials Fall Behind on Enrollment

If you’ve run a device study, you’ve probably had the conversation. The one where someone looks at the enrollment curve around week six or eight and says: we’re behind. It’s not a surprise, exactly. Device teams tend to build buffer into their timelines because they’ve learned to expect delays. Site activation takes longer than pharma. […]